BASF receives award for its portfolio of natural cosmetic ingredients
Company recognised for its innovation and continual delivery of new natural ingredients.
The Natural Products Association (NPA) has recognized BASF for having the largest selection of ingredients for cosmetic manufacturers who want to certify their products according to the NPA Natural Standard. The 25th Annual NPA Awards honors outstanding individuals and companies that have made valuable contributions to the success of the natural products industry.
“BASF is a truly innovative company that continues to deliver new natural alternatives for consumers year in and year out,” said Daniel Fabricant, President and CEO of NPA. “We are pleased to honor BASF for their contributions to our industry and to NPA, the nation’s largest and oldest association for natural products.”
The NPA handed out its award during their annual conference The Big Natural in Las Vegas recently. NPA’s Natural Standard and Certification for Personal Care Products is a set of guidelines that dictate whether a product can be deemed truly “natural”, and comes to protect and educate consumers. The standard encompasses all cosmetic personal care products regulated and defined by the FDA, and is based on four evaluated criteria: natural ingredients, safety, responsibility and sustainability.
“Natural and sustainable solutions are clearly valued by a growing portion of consumers and our customers need trustworthy and recognized partners in order to enable their natural products’ offering,” said Daniele Piergentili, Vice President, Home & Personal Care, North America for BASF. “This award is a testament to our continued commitment to lead in the field of natural ingredients with our innovation portfolio.”
The NPA award comes on the heel of several other recent award nominations for BASF’s Care Creations, including the CEW Beauty Award nomination for the ingredient Dermagenist®, and the Independent Chemical Information Service (ICIS) award nomination for product innovation for the BASF surfactants.
The BASF portfolio for natural cosmetics ranges from basic raw materials – like surfactants and emollients – to additives and active ingredients. Besides the NPA Natural Standard, BASF supports their customers also with all necessary information and data for the COSMOS and NATRUE standards as well as the ISO 16128 norm. Around 130 ingredients developed by BASF for personal care applications have already been registered with COSMOS and more than 50 of the products are evaluated according to the NATRUE criteria. That makes BASF the largest provider of raw materials that are suitable for natural and organic cosmetic products under the COSMOS and NATRUE standards.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance